ArticleJournal of experimental & clinical cancer research : CR2018

Regorafenib suppresses colon tumorigenesis and the generation of drug resistant cancer stem-like cells via modulation of miR-34a associated signaling.

Mao-Hua Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.